Gevo, Inc.

Gevo's withdrawal of its DOE loan application is seen as a strategic pivot, with CEO Paul Bloom indicating the company is actively pursuing alternative financing to fund the ATJ-30 project by end of 2026. The existing GND facility is already cash-generating, providing an economic foundation for future SAF expansion.

The withdrawal of Gevo's DOE loan application triggered a 12% premarket stock drop, exposing deep concerns about the company's ability to fund large-scale SAF projects. With the company still unprofitable at -$0.14 EPS over the last twelve months, securing alternative financing on viable commercial terms remains highly uncertain.

Q2 2026 execution positions Gevo to potentially more than double its prior 2026 Adjusted EBITDA estimate, targeting over $70M. CEO Paul Bloom highlighted new carbon pathways, debottlenecking operations, cost improvements, and Section 45Z tax credits as key drivers expected to generate positive operating margins.

Despite top-line growth, Gevo continues to miss revenue estimates and post recurring losses. The company reported -$0.09 EPS in Q1 2026, significantly missing the -$0.01 forecast, and analysts project a -$0.11 EPS for the full fiscal year, with a negative net margin of 19.38% and negative return on equity of 5.06%.

HC Wainwright reaffirmed a Buy rating and Northland Securities set a $3.50 Outperform target, with the average analyst price target of $2.75 sitting well above the current trading price near $1.48–$1.54. Gevo's forward PS ratio is considered undervalued, and an AI-driven analysis assigns it a 58.74% probability of outperforming the S&P 500 over three months.

Weiss Ratings maintained a Sell (D-) rating, Wall Street Zen downgraded to Strong Sell, and Zacks Research had previously rated shares Strong Sell before upgrading to Hold. Analyst target prices range only from $2.00 to $3.50, reflecting persistent skepticism about Gevo's fundamentals and its ability to justify a higher valuation while remaining unprofitable.